Details of Drug

Drug General Information (ID: D0872)
Drug Name	Ivosidenib
Drug Type	Small molecule
Drug Synonymous	UNII-Q2PCN8MAM6; Q2PCN8MAM6; Ivosidenib [INN]; Ivosidenib [USAN]; Ivosidenib [WHO-DD]; GTPL9217; SCHEMBL15122512; EX-A992; MolPort-044-560-317; RG120; s8206; 1448347-49-6 (Ivosidenib); AKOS028113340; ZINC205136523; CS-5122; AS-35058; HY-18767 Click to Show/Hide
Disease Class	2B33: Malignant haematopoietic neoplasm; 2A60: Acute myeloid leukaemia; 2C12: Liver cancer
Therapeutic Class	Antineoplastics
Structure
Structure	3D Structure		2D Structure
Formula	C28H22ClF3N6O3
InChI	1S/C28H22ClF3N6O3/c29-21-4-2-1-3-20(21)25(26(40)36-18-11-28(31,32)12-18)37(19-10-17(30)14-34-15-19)27(41)22-5-6-24(39)38(22)23-9-16(13-33)7-8-35-23/h1-4,7-10,14-15,18,22,25H,5-6,11-12H2,(H,36,40)/t22-,25-/m0/s1
InChIKey	WIJZXSAJMHAVGX-DHLKQENFSA-N
Canonical SMILES	C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N
External Link
	Pubchem ID	71657455
	CAS Number	1448347-49-6
	CHEBI ID	145430
	TTD ID	D07DCG
	VARIDT ID	DR00362

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM074 Increased risk of peripheral neuropathy BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias
Relation Graph

Full list of drugs interacting with Ivosidenib
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 20
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0116		Atazanavir	C38H52N6O7	148192	Major		Inter Info	[2]
D0192		Boceprevir	C27H45N5O5	10324367	Major		Inter Info	[2], [25]
D0349		Clarithromycin	C38H69NO13	84029	Major		Inter Info	[2]
D0375		Cobicistat	C40H53N7O5S2	25151504	Major		Inter Info	[2]
D0386		Conivaptan	C32H26N4O2	151171	Major		Inter Info	[2]
D0439		Delavirdine	C22H28N6O3S	5625	Major		Inter Info	[2], [25]
D0789		Idelalisib	C22H18FN7O	11625818	Major		Inter Info	[2]
D0799		Indinavir	C36H47N5O4	5362440	Major		Inter Info	[2]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Major		Inter Info	[2]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Major		Inter Info	[2]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[51], [52], [53]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Major		Inter Info	[2], [25]
D1117		Nefazodone	C25H32ClN5O2	4449	Major		Inter Info	[2]
D1119		Nelfinavir	C32H45N3O4S	64143	Major		Inter Info	[2]
D1315		Posaconazole	C37H42F2N8O4	468595	Major		Inter Info	[2]
D1415		Ritonavir	C37H48N6O5S2	392622	Major		Inter Info	[2]
D1541		Telaprevir	C36H53N7O6	3010818	Major		Inter Info	[2], [25]
D1544		Telithromycin	C43H65N5O10	3002190	Major		Inter Info	[2], [25]
D1653		Troleandomycin	C41H67NO15	202225	Major		Inter Info	[2], [25]
D1706		Voriconazole	C16H14F3N5O	71616	Major		Inter Info	[2]
	CYP450 enzyme induction					Drug Num: 181
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0080		Amprenavir	C25H35N3O6S	65016	Major		Inter Info	[11], [2]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Major		Inter Info	[2]
D0100		Aprepitant	C23H21F7N4O3	135413536	Major		Inter Info	[2]
D0226		Butorphanol	C21H29NO2	5361092	Major		Inter Info	[11], [12], [4], [26], [27], [28], [29], [30], [31], [32]
D0255		Carbamazepine	C15H12N2O	2554	Major		Inter Info	[2]
D0413		Dalfopristin	C34H50N4O9S	6323289	Major		Inter Info	[11], [2]
D0497		Diltiazem	C22H26N2O4S	39186	Major		Inter Info	[2]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Major		Inter Info	[2]
D0597		Erythromycin	C37H67NO13	12560	Major		Inter Info	[2]
D0646		Fentanyl	C22H28N2O	3345	Major		Inter Info	[11], [12], [4], [26], [27], [28], [29], [30], [31], [32]
D0667		Fluconazole	C13H12F2N6O	3365	Major		Inter Info	[2]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Major		Inter Info	[2]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Major		Inter Info	[2]
D0697		Fosphenytoin	C16H15N2O6P	56339	Major		Inter Info	[2]
D0772		Hydrocodone	C18H21NO3	5284569	Major		Inter Info	[11], [12], [4], [26], [27], [28], [29], [30], [31], [32]
D0793		Imatinib	C29H31N7O	5291	Major		Inter Info	[2]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Major		Inter Info	[2]
D0161		Benzhydrocodone	C25H25NO4	49836084	Major		Inter Info	[29], [30], [31]
D0906		Letermovir	C29H28F4N4O4	45138674	Major		Inter Info	[2]
D0958		Lumacaftor	C24H18F2N2O5	16678941	Major		Inter Info	[55], [2]
D0959		Lumateperone	C24H28FN3O	21302490	Major		Inter Info	[56]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[2]
D1078		Mitotane	C14H10Cl4	4211	Major		Inter Info	[2]
D1203		Oxycodone	C18H21NO4	5284603	Major		Inter Info	[11], [12], [4], [26], [27], [28], [29], [30], [31], [32]
D1265		Phenobarbital	C12H12N2O3	4763	Major		Inter Info	[2]
D1283		Phenytoin	C15H12N2O2	1775	Major		Inter Info	[2]
D1340		Primidone	C12H14N2O2	4909	Major		Inter Info	[2]
D1400		Rifampicin	C43H58N4O12	135398735	Major		Inter Info	[55], [2]
D1401		Rifapentine	C47H64N4O12	135403821	Major		Inter Info	[2]
D1502		St. John's Wort	NA	NA	Major		Inter Info	[2]
D1505		Stiripentol	C14H18O3	5311454	Major		Inter Info	[2]
D1690		Verapamil	C27H38N2O4	2520	Major		Inter Info	[2]
D0006		Abemaciclib	C27H32F2N8	46220502	Moderate		Inter Info	[135]
D0008		Acalabrutinib	C26H23N7O2	71226662	Moderate		Inter Info	[136]
D0035		Alfentanil	C21H32N6O3	51263	Moderate		Inter Info	[137], [138], [139], [140]
D0044		Alpelisib	C19H22F3N5O2S	56649450	Moderate		Inter Info	[141]
D0045		Alprazolam	C17H13ClN4	2118	Moderate		Inter Info	[2]
D0069		Amlodipine	C20H25ClN2O5	2162	Moderate		Inter Info	[2]
D0096		Apixaban	C25H25N5O4	10182969	Moderate		Inter Info	[142]
D0099		Apremilast	C22H24N2O7S	11561674	Moderate		Inter Info	[143]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[147]
D0106		Armodafinil	C15H15NO2S	9690109	Moderate		Inter Info	[148], [149]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[150], [151], [152], [153], [154]
D0128		Avanafil	C23H26ClN7O3	9869929	Moderate		Inter Info	[155]
D0133		Axitinib	C22H18N4OS	6450551	Moderate		Inter Info	[156], [157]
D0181		Bictegravir	C21H18F3N3O5	90311989	Moderate		Inter Info	[4], [158], [159]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[12], [4], [163]
D0222		Buspirone	C21H31N5O2	2477	Moderate		Inter Info	[164], [165], [166]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[167]
D0251		Capmatinib	C23H17FN6O	25145656	Moderate		Inter Info	[168]
D0262		Cariprazine	C21H32Cl2N4O	11154555	Moderate		Inter Info	[4], [169]
D0268		Caspofungin	C52H88N10O15	2826718	Moderate		Inter Info	[170]
D0376		Cobimetinib	C21H21F3IN3O2	16222096	Moderate		Inter Info	[171]
D0380		Colchicine	C22H25NO6	6167	Moderate		Inter Info	[2]
D0387		Conjugated estrogens	C18H21NaO5S	45357473	Moderate		Inter Info	[172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218]
D0389		Copanlisib	C23H28N8O4	135565596	Moderate		Inter Info	[219]
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[2]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[4], [220]
D0424		Darifenacin	C28H30N2O2	444031	Moderate		Inter Info	[221]
D0425		Darolutamide	C19H19ClN6O2	67171867	Moderate		Inter Info	[222]
D0494		Dihydroergotamine	C33H37N5O5	10531	Moderate		Inter Info	[12], [4], [223]
D0511		Docetaxel	C43H53NO14	148124	Moderate		Inter Info	[224], [225], [226], [227], [228]
D0516		Donepezil	C24H29NO3	3152	Moderate		Inter Info	[229]
D0518		Doravirine	C17H11ClF3N5O3	58460047	Moderate		Inter Info	[230], [22]
D0536		Drospirenone	C24H30O3	68873	Moderate		Inter Info	[2]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[231]
D0555		Elagolix	C32H30F5N3O5	11250647	Moderate		Inter Info	[232]
D0556		Elbasvir	C49H55N9O7	71661251	Moderate		Inter Info	[233]
D0559		Eliglustat	C23H36N2O4	23652731	Moderate		Inter Info	[234]
D0563		Elvitegravir	C23H23ClFNO5	5277135	Moderate		Inter Info	[12], [4], [235]
D0590		Erdafitinib	C25H30N6O2	67462786	Moderate		Inter Info	[236]
D0592		Ergometrine	C19H23N3O2	443884	Moderate		Inter Info	[12], [4], [223]
D0593		Ergotamine	C33H35N5O5	8223	Moderate		Inter Info	[12], [4], [223]
D0595		Erlotinib	C22H23N3O4	176870	Moderate		Inter Info	[237], [238]
D0605		Esterified estrogens	NA	NA	Moderate		Inter Info	[172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218]
D0606		Estradiol	C18H24O2	5757	Moderate		Inter Info	[172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218]
D0607		Estradiol (topical)	C18H24O2	5757	Moderate		Inter Info	[176], [186], [211]
D0609		Estrone	C18H22O2	5870	Moderate		Inter Info	[172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218]
D0610		Estrone sulfate	C18H22O5S	3001028	Moderate		Inter Info	[176], [186], [211]
D0612		Eszopiclone	C17H17ClN6O3	969472	Moderate		Inter Info	[239]
D0619		Ethinylestradiol	C20H24O2	5991	Moderate		Inter Info	[240], [2]
D0626		Etonogestrel	C22H28O2	6917715	Moderate		Inter Info	[2]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[241]
D0629		Everolimus	C53H83NO14	6442177	Moderate		Inter Info	[12], [4], [242]
D0630		Exemestane	C20H24O2	60198	Moderate		Inter Info	[243]
D0640		Felodipine	C18H19Cl2NO4	3333	Moderate		Inter Info	[2]
D0655		Fesoterodine	C26H37NO3	6918558	Moderate		Inter Info	[245]
D0665		Flibanserin	C20H21F3N4O	6918248	Moderate		Inter Info	[246]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[247]
D0713		Gefitinib	C22H24ClFN4O3	123631	Moderate		Inter Info	[237], [248]
D0726		Glecaprevir	C38H46F4N6O9S	66828839	Moderate		Inter Info	[249]
D0745		Guanfacine	C9H9Cl2N3O	3519	Moderate		Inter Info	[4], [250], [251]
D0785		Ibrutinib	C25H24N6O2	24821094	Moderate		Inter Info	[252]
D0845		Irinotecan	C33H38N4O6	60838	Moderate		Inter Info	[253], [254], [255], [256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267]
D0846		Irinotecan (liposomal)	C33H38N4O6	60838	Moderate		Inter Info	[254], [255], [260]
D0865		Isradipine	C19H21N3O5	3784	Moderate		Inter Info	[2]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[268], [269], [270], [271]
D0129		Avapritinib	C26H27FN10	118023034	Moderate		Inter Info	[4], [272]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[12], [4], [273]
D1242		Pemigatinib	C24H27F2N5O4	86705695	Moderate		Inter Info	[4], [274]
D1409		Ripretinib	C24H21BrFN5O2	71584930	Moderate		Inter Info	[12], [275]
D1663		Ubrogepant	C29H26F3N5O3	68748835	Moderate		Inter Info	[276]
D1718		Zanubrutinib	C27H29N5O3	135565884	Moderate		Inter Info	[277]
D0873		Ixabepilone	C27H42N2O5S	6445540	Moderate		Inter Info	[278]
D0874		Ixazomib	C14H19BCl2N2O4	25183872	Moderate		Inter Info	[279]
D0901		Lemborexant	C22H20F2N4O2	56944144	Moderate		Inter Info	[12], [280]
D0911		Levamlodipine	C20H25ClN2O5	9822750	Moderate		Inter Info	[2]
D0922		Levonorgestrel	C21H28O2	13109	Moderate		Inter Info	[2]
D0930		Linagliptin	C25H28N8O2	10096344	Moderate		Inter Info	[281]
D0956		Lovastatin	C24H36O5	53232	Moderate		Inter Info	[2]
D0961		Lurasidone	C28H36N4O2S	213046	Moderate		Inter Info	[12], [4], [284]
D0962		Lurbinectedin	C41H44N4O10S	57327016	Moderate		Inter Info	[285]
D0966		Macitentan	C19H20Br2N6O4S	16004692	Moderate		Inter Info	[286], [287]
D0980		Maraviroc	C29H41F2N5O	3002977	Moderate		Inter Info	[12], [288]
D0990		Medroxyprogesterone acetate	C24H34O4	6279	Moderate		Inter Info	[240], [2]
D0993		Megestrol acetate	C24H32O4	11683	Moderate		Inter Info	[176], [186], [211]
D1037		Methylergometrine	C20H25N3O2	8226	Moderate		Inter Info	[12], [4], [223]
D1043		Methysergide	C21H27N3O2	9681	Moderate		Inter Info	[12], [4], [223]
D1060		Midazolam	C18H13ClFN3	4192	Moderate		Inter Info	[2]
D1081		Modafinil	C15H15NO2S	4236	Moderate		Inter Info	[148], [149]
D1087		Montelukast	C35H36ClNO3S	5281040	Moderate		Inter Info	[289]
D1104		Naloxegol	C34H53NO11	56959087	Moderate		Inter Info	[290]
D1134		Nifedipine	C17H18N2O6	4485	Moderate		Inter Info	[2]
D1138		Nimodipine	C21H26N2O7	4497	Moderate		Inter Info	[2]
D1141		Nisoldipine	C20H24N2O6	4499	Moderate		Inter Info	[2]
D1143		Nitisinone	C14H10F3NO5	115355	Moderate		Inter Info	[11], [12], [4]
D1154		Norethisterone	C20H26O2	6230	Moderate		Inter Info	[240], [2]
D1157		Norgestrel	C21H28O2	13109	Moderate		Inter Info	[2]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[12], [4], [292]
D1212		Paclitaxel	C47H51NO14	36314	Moderate		Inter Info	[293], [294], [295], [296]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[293], [294], [295]
D1214		Palbociclib	C24H29N7O2	5330286	Moderate		Inter Info	[12], [4], [297]
D1253		Perampanel	C23H15N3O	9924495	Moderate		Inter Info	[4], [1]
D1313		Ponatinib	C29H27F3N6O	24826799	Moderate		Inter Info	[12], [4], [300]
D1330		Praziquantel	C19H24N2O2	4891	Moderate		Inter Info	[301], [12], [302], [303]
D1348		Progesterone	C21H30O2	5994	Moderate		Inter Info	[172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218]
D1349		Progesterone (topical)	C21H30O2	5994	Moderate		Inter Info	[176], [186], [211]
D1370		Quinestrol	C25H32O2	9046	Moderate		Inter Info	[172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218]
D1378		Ramelteon	C16H21NO2	208902	Moderate		Inter Info	[314]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[315], [316], [317]
D1408		Riociguat	C20H19FN8O2	11304743	Moderate		Inter Info	[318]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Moderate		Inter Info	[319]
D1423		Rolapitant	C25H26F6N2O2	10311306	Moderate		Inter Info	[320]
D1434		Ruxolitinib	C17H18N6	25126798	Moderate		Inter Info	[321]
D1449		Saxagliptin	C18H25N3O2	11243969	Moderate		Inter Info	[322]
D1460		Selumetinib	C17H15BrClFN4O3	10127622	Moderate		Inter Info	[323]
D1465		Sildenafil	C22H30N6O4S	135398744	Moderate		Inter Info	[324], [325], [326], [327]
D1466		Silodosin	C25H32F3N3O4	5312125	Moderate		Inter Info	[12], [4], [328]
D1473		Simvastatin	C25H38O5	54454	Moderate		Inter Info	[2]
D1476		Sirolimus	C51H79NO13	5284616	Moderate		Inter Info	[12], [4], [329], [330]
D1496		Sonidegib	C26H26F3N3O3	24775005	Moderate		Inter Info	[331]
D1512		Sufentanil	C22H30N2O2S	41693	Moderate		Inter Info	[2]
D1524		Suvorexant	C23H23ClN6O2	24965990	Moderate		Inter Info	[332]
D1527		Tadalafil	C22H19N3O4	110635	Moderate		Inter Info	[4], [333], [334]
D1536		Tasimelteon	C15H19NO2	10220503	Moderate		Inter Info	[335]
D1538		Tazemetostat	C34H44N4O4	66558664	Moderate		Inter Info	[2]
D1549		Temsirolimus	C56H87NO16	6918289	Moderate		Inter Info	[12], [4], [336]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Moderate		Inter Info	[11], [4], [338], [339], [340]
D1592		Tipranavir	C31H33F3N2O5S	54682461	Moderate		Inter Info	[341], [342], [343], [11], [344], [345], [346], [347], [348], [349], [99], [350], [351], [352], [353], [354], [355]
D1600		Tofacitinib	C16H20N6O	9926791	Moderate		Inter Info	[12], [356]
D1608		Tolvaptan	C26H25ClN2O3	216237	Moderate		Inter Info	[4], [357]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[4], [358], [359]
D1632		Triazolam	C17H12Cl2N4	5556	Moderate		Inter Info	[2]
D1660		Tucatinib	C26H24N8O2	51039094	Moderate		Inter Info	[360], [361], [362]
D1688		Venetoclax	C45H50ClN7O7S	49846579	Moderate		Inter Info	[2]
D1696		Vilazodone	C26H27N5O2	6918314	Moderate		Inter Info	[363]
D1697		Vinblastine	C46H58N4O9	13342	Moderate		Inter Info	[2]
D1698		Vincristine	C46H56N4O10	5978	Moderate		Inter Info	[2]
D1699		Vincristine (liposome)	C46H56N4O10	5978	Moderate		Inter Info	[2]
D1700		Vinorelbine	C45H54N4O8	5311497	Moderate		Inter Info	[2]
D1708		Vortioxetine	C18H22N2S	9966051	Moderate		Inter Info	[364]
D1729		Zolpidem	C19H21N3O	5732	Moderate		Inter Info	[4], [365], [366], [367]
D1730		Zonisamide	C8H8N2O3S	5734	Moderate		Inter Info	[368], [369]
D0178		Bexarotene	C24H28O2	82146	Minor		Inter Info	[370]
D0193		Bortezomib	C19H25BN4O4	387447	Minor		Inter Info	[4], [371], [372], [373], [374]
D0308		Cevimeline	C10H17NOS	83898	Minor		Inter Info	[375]
D0420		Dapsone (topical)	C12H12N2O2S	2955	Minor		Inter Info	[376], [268], [271]
D0515		Dolutegravir	C20H19F2N3O5	54726191	Minor		Inter Info	[377]
D0916		Levobupivacaine	C18H28N2O	92253	Minor		Inter Info	[55], [378]
D0927		Lidocaine	C14H22N2O	3676	Minor		Inter Info	[379], [380], [381], [382]
D1074		Mirabegron	C21H24N4O2S	9865528	Minor		Inter Info	[386]
Pharmacodynamic additive effects
	Increased risk of prolong QT interval					Drug Num: 170
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0003		Abarelix	C72H95ClN14O14	16131215	Major		Inter Info	[1], [2]
D0007		Abiraterone	C24H31NO	132971	Major		Inter Info	[2]
D0036		Alfuzosin	C19H27N5O4	2092	Major		Inter Info	[2]
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[11], [12], [4], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22]
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[2]
D0068		Amitriptyline	C20H23N	2160	Major		Inter Info	[2]
D0072		Amoxapine	C17H16ClN3O	2170	Major		Inter Info	[2]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[2]
D0097		Apomorphine	C17H17NO2	6005	Major		Inter Info	[2]
D0112		Asenapine	C17H16ClNO	3036780	Major		Inter Info	[2]
D0115		Astemizole	C28H31FN4O	2247	Major		Inter Info	[1], [2]
D0119		Atomoxetine	C17H21NO	54841	Major		Inter Info	[2]
D0139		Azithromycin	C38H72N2O12	447043	Major		Inter Info	[2]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[2]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[11], [16], [21]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Major		Inter Info	[2]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Major		Inter Info	[2]
D0219		Buprenorphine	C29H41NO4	644073	Major		Inter Info	[2]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[2]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[2]
D0324		Chlorpromazine	C17H19ClN2S	2726	Major		Inter Info	[2]
D0336		Cilostazol	C20H27N5O2	2754	Major		Inter Info	[2]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Major		Inter Info	[2]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[11], [12], [33]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[11], [12], [4], [34], [35], [22], [36]
D0358		Clofazimine	C27H22Cl2N4	2794	Major		Inter Info	[1], [2]
D0361		Clomipramine	C19H23ClN2	2801	Major		Inter Info	[2]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[2]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Major		Inter Info	[2]
D0429		Daunorubicin	C27H29NO10	30323	Major		Inter Info	[2]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Major		Inter Info	[1], [2]
D0437		Degarelix	C82H103ClN18O16	16136245	Major		Inter Info	[2]
D0446		Desipramine	C18H22N2	2995	Major		Inter Info	[2]
D0452		Deutetrabenazine	C19H27NO3	73437646	Major		Inter Info	[2]
D0467		Dextropropoxyphene	C22H29NO2	10100	Major		Inter Info	[1], [2]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[11], [12], [4], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[11], [12], [4], [37]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[2]
D0526		Doxepin (topical)	C19H21NO	667477	Major		Inter Info	[1], [2]
D0528		Doxorubicin	C27H29NO11	31703	Major		Inter Info	[2]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Major		Inter Info	[1], [2]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[2]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[38]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Major		Inter Info	[2]
D0577		Entrectinib	C31H34F2N6O2	25141092	Major		Inter Info	[1], [2]
D0584		Epirubicin	C27H29NO11	41867	Major		Inter Info	[2]
D0594		Eribulin	C40H59NO11	11354606	Major		Inter Info	[2]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[2]
D0632		Ezogabine	C16H18FN3O2	121892	Major		Inter Info	[1], [2]
D0664		Flecainide	C17H20F6N2O3	3356	Major		Inter Info	[2]
D0676		Fluoxetine	C17H18F3NO	3386	Major		Inter Info	[2]
D0678		Fluphenazine	C22H26F3N3OS	3372	Major		Inter Info	[2]
D0682		Flutamide	C11H11F3N2O3	3397	Major		Inter Info	[2]
D0694		Foscarnet	CH3O5P	3415	Major		Inter Info	[2]
D0700		Fostemsavir	C25H26N7O8P	11319217	Major		Inter Info	[1], [2]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[40], [11], [41]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Major		Inter Info	[2]
D0720		Gilteritinib	C29H44N8O3	49803313	Major		Inter Info	[2]
D0725		Glasdegib	C21H22N6O	25166913	Major		Inter Info	[1], [2]
D0737		Goserelin	C59H84N18O14	5311128	Major		Inter Info	[2]
D0738		Granisetron	C18H24N4O	5284566	Major		Inter Info	[2]
D0740		Grepafloxacin	C19H22FN3O3	72474	Major		Inter Info	[12], [4], [42]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[12], [43], [44]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[2]
D0751		Halothane	C2HBrClF3	3562	Major		Inter Info	[2]
D0758		Histrelin	C66H86N18O12	25077993	Major		Inter Info	[2]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[2]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Major		Inter Info	[2]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[2]
D0788		Idarubicin	C26H27NO9	42890	Major		Inter Info	[2]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[11], [12], [4], [45], [22]
D0795		Imipramine	C19H24N2	3696	Major		Inter Info	[2]
D0806		Inotuzumab ozogamicin	NA	NA	Major		Inter Info	[2]
D1169		Oliceridine	C22H30N2O2S	66553195	Major		Inter Info	[1], [2]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[1], [2]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Major		Inter Info	[2]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Major		Inter Info	[2]
D0908		Leuprolide	C59H84N16O12	657181	Major		Inter Info	[2]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[4], [54], [22]
D0919		Levofloxacin	C18H20FN3O4	149096	Major		Inter Info	[2]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Major		Inter Info	[2]
D0940		Lithium carbonate	CLi2O3	11125	Major		Inter Info	[1], [2]
D0942		Lofexidine	C11H12Cl2N2O	30668	Major		Inter Info	[2]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Major		Inter Info	[1], [2]
D0960		Lumefantrine	C30H32Cl3NO	6437380	Major		Inter Info	[12], [4], [57]
D0965		Macimorelin	C26H30N6O3	9804938	Major		Inter Info	[1], [58], [59]
D0979		Maprotiline	C20H23N	4011	Major		Inter Info	[2]
D0992		Mefloquine	C17H16F6N2O	4046	Major		Inter Info	[2]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[12], [4], [60]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[2]
D1026		Methotrimeprazine	C19H24N2OS	72287	Major		Inter Info	[1], [2]
D1062		Midostaurin	C35H30N4O4	9829523	Major		Inter Info	[2]
D1075		Mirtazapine	C17H19N3	4205	Major		Inter Info	[2]
D1092		Moxifloxacin	C21H24FN3O4	152946	Major		Inter Info	[40], [61], [62], [11], [12], [4], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [41], [79], [80], [81]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[11], [12], [4], [82]
D1137		Nilutamide	C12H10F3N3O4	4493	Major		Inter Info	[2]
D1155		Norfloxacin	C16H18FN3O3	4539	Major		Inter Info	[1], [2]
D1158		Nortriptyline	C19H21N	4543	Major		Inter Info	[2]
D1165		Ofloxacin	C18H20FN3O4	4583	Major		Inter Info	[2]
D1181		Ondansetron	C18H19N3O	4595	Major		Inter Info	[2]
D1189		Osilodrostat	C13H10FN3	44139752	Major		Inter Info	[1], [2]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[2]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Major		Inter Info	[2]
D1210		Oxytocin	C43H66N12O12S2	439302	Major		Inter Info	[2]
D1215		Paliperidone	C23H27FN4O3	115237	Major		Inter Info	[2]
D1216		Palonosetron	C19H24N2O	6337614	Major		Inter Info	[2]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[84]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[85], [86], [87], [88], [89], [90], [91], [92]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[2]
D1232		Pazopanib	C21H23N7O2S	10113978	Major		Inter Info	[2]
D1246		Pentamidine	C19H24N4O2	4735	Major		Inter Info	[2]
D1254		Perflutren	C3F8	6432	Major		Inter Info	[93], [94]
D1257		Perphenazine	C21H26ClN3OS	4748	Major		Inter Info	[2]
D1290		Pimavanserin	C25H34FN3O2	10071196	Major		Inter Info	[2]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[4], [95], [96], [22]
D1302		Pitolisant	C17H26ClNO	9948102	Major		Inter Info	[2]
D1339		Primaquine	C15H21N3O	4908	Major		Inter Info	[2]
D1342		Probucol	C31H48O2S2	4912	Major		Inter Info	[1], [2]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[11], [12], [4], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22]
D1346		Prochlorperazine	C20H24ClN3S	4917	Major		Inter Info	[2]
D1351		Promazine	C17H20N2S	4926	Major		Inter Info	[1], [2]
D1352		Promethazine	C17H20N2S	4927	Major		Inter Info	[2]
D1353		Propafenone	C21H27NO3	4932	Major		Inter Info	[2]
D1361		Protriptyline	C19H21N	4976	Major		Inter Info	[2]
D1368		Quetiapine	C21H25N3O2S	5002	Major		Inter Info	[2]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[11], [12], [4], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22]
D1372		Quinine	C20H24N2O2	3034034	Major		Inter Info	[2]
D1383		Ranolazine	C24H33N3O4	56959	Major		Inter Info	[2]
D1388		Relugolix	C29H27F2N7O5S	10348973	Major		Inter Info	[2]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[2]
D1404		Rilpivirine	C22H18N6	6451164	Major		Inter Info	[2]
D1413		Risperidone	C23H27FN4O2	5073	Major		Inter Info	[2]
D1424		Romidepsin	C24H36N4O6S2	5352062	Major		Inter Info	[1], [2]
D1432		Rucaparib	C19H18FN3O	9931954	Major		Inter Info	[2]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[97], [98], [11], [12], [4], [99], [100]
D1461		Sertraline	C17H17Cl2N	68617	Major		Inter Info	[2]
D1463		Sevoflurane	C4H3F7O	5206	Major		Inter Info	[2]
D1491		Solifenacin	C23H26N2O2	154059	Major		Inter Info	[2]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Major		Inter Info	[2]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[11], [12], [4], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Major		Inter Info	[102], [103], [104]
D1522		Sunitinib	C22H27FN4O2	5329102	Major		Inter Info	[2]
D1526		Tacrolimus	C44H69NO12	445643	Major		Inter Info	[2]
D1533		Tamoxifen	C26H29NO	2733526	Major		Inter Info	[2]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Major		Inter Info	[2]
D1555		Terfenadine	C32H41NO2	5405	Major		Inter Info	[1], [2]
D1560		Tetrabenazine	C19H27NO3	6018	Major		Inter Info	[2]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[4], [129], [130]
D1596		Tizanidine	C9H8ClN5S	5487	Major		Inter Info	[2]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[11], [12], [4], [131]
D1616		Tramadol	C16H25NO2	33741	Major		Inter Info	[2]
D1624		Trazodone	C19H22ClN5O	5533	Major		Inter Info	[2]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Major		Inter Info	[1], [2]
D1637		Trifluoperazine	C21H24F3N3S	5566	Major		Inter Info	[2]
D1638		Triflupromazine	C18H19F3N2S	5568	Major		Inter Info	[1], [2]
D1647		Trimipramine	C20H26N2	5584	Major		Inter Info	[2]
D1651		Triptorelin	C64H82N18O13	25074470	Major		Inter Info	[2]
D1673		Valbenazine	C24H38N2O4	24795069	Major		Inter Info	[2]
D1681		Vandetanib	C22H24BrFN4O2	3081361	Major		Inter Info	[11], [12], [4], [132]
D1682		Vardenafil	C23H32N6O4S	135400189	Major		Inter Info	[2]
D1683		Vasopressin	C46H65N15O12S2	644077	Major		Inter Info	[2]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[11], [12], [4], [133]
D1689		Venlafaxine	C17H27NO2	5656	Major		Inter Info	[2]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[11], [12], [4], [95], [134], [22]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[12], [4], [244]
D0947		Loperamide	C29H33ClN2O2	3955	Moderate		Inter Info	[282], [283]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[12], [4], [291]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[304], [305], [306], [307], [308], [309], [310], [311], [312], [313]
D1051		Metronidazole	C6H9N3O3	4173	Minor		Inter Info	[12], [383], [384], [385]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[11], [12], [387]
	Increased risk of ventricular arrhythmias					Drug Num: 34
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0025		Adenosine	C10H13N5O4	60961	Major		Inter Info	[3], [4], [5], [6], [7], [8], [9], [10]
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[23], [24]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[11], [12], [4], [39], [36]
D0859		Isoprenaline	C11H17NO3	3779	Major		Inter Info	[46], [47], [48]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[4], [49], [50]
D1185		Orciprenaline	C11H17NO3	4086	Major		Inter Info	[46], [47], [48]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[83]
D1414		Ritodrine	C17H21NO3	33572	Major		Inter Info	[46], [47], [48]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[12], [101]
D1554		Terbutaline	C12H19NO3	5403	Major		Inter Info	[46], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [47], [123], [124], [125], [126], [48], [127], [128]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[46], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [144], [145], [117], [118], [119], [120], [121], [146], [122], [47], [123], [124], [125], [126], [48], [127], [128]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[11], [12], [4], [160], [161], [162]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[11], [12], [4], [160], [161], [162]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[46], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [144], [145], [117], [118], [119], [120], [121], [146], [122], [47], [123], [124], [125], [126], [48], [127], [128]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[11], [12], [4], [160], [161], [162]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[46], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [144], [145], [117], [118], [119], [120], [121], [146], [122], [47], [123], [124], [125], [126], [48], [127], [128]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[12], [4], [162]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[11], [12], [4], [160], [161], [162]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[11], [12], [4], [160], [161], [162]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[144], [123], [126]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[11], [12], [4], [160], [161], [162]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[11], [12], [4], [160], [161], [162]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[11], [12], [4], [160], [161], [162]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[46], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [144], [145], [117], [118], [119], [120], [121], [146], [122], [47], [123], [124], [125], [126], [48], [127], [128]
D1266		Phenolphthalein	C20H14O4	4764	Moderate		Inter Info	[11], [12], [4], [160], [161], [162]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[4], [298], [299]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[46], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [144], [145], [117], [118], [119], [120], [121], [146], [122], [47], [123], [124], [125], [126], [48], [127], [128]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[4], [298], [299]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[12], [4], [162]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[109], [115], [120]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[46], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [144], [145], [117], [118], [119], [120], [121], [146], [122], [47], [123], [124], [125], [126], [48], [127], [128]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[4], [298], [299]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[12], [4], [337]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[144], [123], [126]

References
1	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
2	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
3	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
4	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
5	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
6	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
7	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
8	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
9	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
10	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
11	Canadian Pharmacists Association.
12	Cerner Multum, Inc. "Australian Product Information.".
13	Maxa JL, Hebeler RF, Adeeko MA "Torsades de pointes following concurrent amiodarone and levofloxacin therapy." Proc (Bayl Univ Med Cent) 19 (2006): 345-6. [PMID: 17106497]
14	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
15	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
16	Product Information. Norpace (disopyramide). Searle, Skokie, IL.
17	Product Information. Procan SR (procainamide). Parke-Davis, Morris Plains, NJ.
18	Product Information. Quiniglute (quinidine). Berlex, Richmond, CA.
19	Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.
20	Trujillo TC, Nolan PE "Antiarrhythmic agents - Drug interactions of clinical significance." Drug Safety 23 (2000): 509-32. [PMID: 11144659]
21	Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
22	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
23	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
24	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
25	Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm 66 (2009): 1438-67. [PMID: 19667002]
26	Product Information. Butorphanol Tartrate (butorphanol). Apotex Corporation, Weston, FL.
27	Product Information. Duragesic Transdermal System (fentanyl). Janssen Pharmaceutica, Titusville, NJ.
28	Product Information. Ionsys (fentanyl). Ortho McNeil Pharmaceutical, Raritan, NJ.
29	Product Information. Mycobutin (rifabutin). Pharmacia and Upjohn, Kalamazoo, MI.
30	Product Information. OxyContin (oxycodone). Purdue Frederick Company, Norwalk, CT.
31	Product Information. Rifadin (rifampin). Hoechst Marion-Roussel Inc, Kansas City, MO.
32	Product Information. Zohydro ER (HYDROcodone). Zogenix, Inc, San Diego, CA.
33	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
34	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
35	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
36	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
37	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
38	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
39	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
40	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
41	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
42	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
43	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
44	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
45	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
46	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
47	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
48	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
49	Mittal SR "Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine." J Assoc Physicians India 62 (2014): 426-7. [PMID: 25438492]
50	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
51	Product Information. Fareston (toremifene). Schering Laboratories, Kenilworth, NJ.
52	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
53	Therapeutic Research Faculty "Natural Medicines Comprehensive Database.".
54	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
55	Patel S, Robinson R, Burk M "Hypertensive crisis associated with St. John's Wort." Am J Med 112 (2002): 507-8. [PMID: 11959071]
56	Product Information. Caplyta (lumateperone). Intra-Cellular Therapies, Inc., New York, NY.
57	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
58	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
59	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
60	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
61	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
62	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
63	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
64	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
65	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
66	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
67	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
68	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
69	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
70	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
71	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
72	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
73	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
74	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
75	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
76	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
77	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
78	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
79	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
80	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
81	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
82	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
83	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
84	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
85	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
86	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
87	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
88	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
89	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
90	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
91	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
92	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
93	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
94	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
95	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
96	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
97	Anson BD, Weaver JG, Ackerman MJ, et al. "Blockade of HERG channels by HIV protease inhibitors." Lancet 365 (2005): 682-686. [PMID: 15721475]
98	Biondi L "Health Canada endorsed important safety information on Invirase (saquinavir mesylate)." .
99	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
100	FDA. U.S. Food and Drug Administration "FDA drug safety communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms.".
101	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
102	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
103	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
104	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
105	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
106	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
107	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
108	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
109	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
110	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
111	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
112	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
113	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
114	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
115	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
116	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
117	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
118	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
119	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
120	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
121	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
122	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
123	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
124	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
125	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
126	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
127	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
128	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
129	Liberatore MA, Robinson DS "Torsade de pointes: a mechanism for sudden death associated with neuroleptic drug therapy?" J Clin Psychopharmacol 4 (1984): 143-6. [PMID: 6145728]
130	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
131	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
132	Product Information. Vandetanib (vandetanib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
133	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
134	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
135	Product Information. Verzenio (abemaciclib). Lilly, Eli and Company, Indianapolis, IN.
136	Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
137	Kharasch ED, Thummel KE "Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?" Anesth Analg 76 (1993): 1033-9. [PMID: 8484504]
138	Koehntop DE, Noormohamed SE, Fletcher CV "Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation." Pharmacotherapy 14 (1994): 592-9. [PMID: 7997393]
139	Labroo RB, Thummel KE, Kunze KL, Podoll T, Trager WF, Kharasch ED "Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism." Drug Metab Dispos 23 (1995): 490-6. [PMID: 7600917]
140	Kharasch ED, Russell M, Mautz D, Thummel KE, Kunze KL, Bowdle A, Cox K "The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions." Anesthesiology 87 (1997): 36-50. [PMID: 9232132]
141	Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
142	Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
143	Product Information. Otezla (apremilast). Celgene Corporation, Summit, NJ.
144	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
145	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
146	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
147	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
148	Product Information. Nuvigil (armodafinil). Cephalon Inc, West Chester, PA.
149	Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
150	Bullman J, Nicholls A, Van Landingham K, et al. "Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers." Epilepsia 52 (2011): 1351-8. [PMID: 21635243]
151	Gerber JG, Rosenkranz SL, Fichtenbaum CJ, et al. "Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study." J Acquir Immune Defic Syndr 39 (2005): 307-12. [PMID: 15980690]
152	Khandwala HM "Lipid lowering inefficacy of high-dose statin therapy due to concurrent use of phenytoin." South Med J 99 (2006): 1385-7. [PMID: 17233196]
153	Murphy MJ, Dominiczak MH "Efficacy of statin therapy: possible effect of phenytoin." Postgrad Med J 75 (1999): 359-60. [PMID: 10435174]
154	Product Information. Lipitor (atorvastatin). Parke-Davis, Morris Plains, NJ.
155	Product Information. Stendra (avanafil). Vivus Inc, Mountain View, CA.
156	Pithavala YK, Tortorici M, Toh M, et al "Effect of rifampin on the pharmacokinetics of axitinib (AG-013736) in Japanese and Caucasian healthy volunteers." Cancer Chemother Pharmacol 65 (2010): 563-70. [PMID: 19603168]
157	Product Information. Inlyta (axitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
158	Product Information. Biktarvy (bictegravir/emtricitabine/tenofovir). Gilead Sciences, Foster City, CA.
159	Product Information. Viread (tenofovir). Gilead Sciences, Foster City, CA.
160	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
161	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
162	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
163	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
164	Kivisto KT, Lamberg TS, Neuvonen PJ "Interactions of buspirone with itraconazole and rifampicin: Effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone." Pharmacol Toxicol 84 (1999): 94-7. [PMID: 10068153]
165	Lamberg TS, Kivisto KT, Neuvonen PJ "Concentrations and effects of buspirone are considerably reduced by rifampicin." Br J Clin Pharmacol 45 (1998): 381-5. [PMID: 9578186]
166	Product Information. Buspar (buspirone). Bristol-Myers Squibb, Princeton, NJ.
167	Product Information. Jevtana (cabazitaxel). sanofi-aventis , Bridgewater, NJ.
168	Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
169	Product Information. Vraylar (cariprazine). Actavis Pharma, Inc., Parsippany, NJ.
170	Product Information. Cancidas (caspofungin) Merck & Co, Inc, West Point, PA.
171	Product Information. Cotellic (cobimetinib). Genentech, South San Francisco, CA.
172	Baciewicz AM "Oral contraceptive drug interactions." Ther Drug Monit 7 (1985): 26-35. [PMID: 2859674]
173	Baciewicz AM, Self TH "Rifampin drug interactions." Arch Intern Med 144 (1984): 1667-71. [PMID: 6380442]
174	Back DJ, Bates M, Bowden A, et al "The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy." Contraception 22 (1980): 495-503. [PMID: 7471739]
175	Back DJ, Breckenridge AM, Crawford FE, et al. "The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women." Contraception 21 (1980): 135-43. [PMID: 7189454]
176	Back DJ, Breckenridge AM, Crawford FE, MacIver M, Orne ML, Rowe PH "Interindividual variation and drug interactions with hormonal steroid contraceptives." Drugs 21 (1981): 46-61. [PMID: 7009137]
177	Back DJ, Orme ML "Pharmacokinetic drug interactions with oral contraceptives." Clin Pharmacokinet 18 (1990): 472-84. [PMID: 2191822]
178	Barditch-Crovo P, Trapnell CB, Ette E, et al "The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive." Clin Pharmacol Ther 65 (1999): 428-38. [PMID: 10223781]
179	Bolt HM, Bolt M, Kappus H "Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man." Acta Endocrinol (Copenh) 85 (1977): 189-97. [PMID: 577076]
180	Borcherding SM, Baciewicz AM, Self TH "Update on rifampin drug interactions." Arch Intern Med 152 (1992): 711-6. [PMID: 1558427]
181	Cote J "Interaction of griseofulvin and oral contraceptives." J Am Acad Dermatol 22 (1990): 124-5. [PMID: 2298948]
182	Coulam CB, Annegers JF "Do anticonvulsants reduce the efficacy of oral contraceptives?" Epilepsia 20 (1979): 519-26. [PMID: 477641]
183	Crawford P, Chadwick DJ, Martin C, et al "The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids." Br J Clin Pharmacol 30 (1990): 892-6. [PMID: 2126946]
184	Curran MA "Drug interactions with the pill." Med J Aust 144 (1986): 670-1. [PMID: 3086681]
185	D'Arcy PF "Drug interactions with oral contraceptives." Drug Intell Clin Pharm 20 (1986): 353-62. [PMID: 3519141]
186	Dickinson BD, Altman RD, Nielsen NH, Sterling ML "Drug interactions between oral contraceptives and antibiotics." Obstet Gynecol 98(5 Pt 1) (2001): 853-60. [PMID: 11704183]
187	D'Arcy PF. Drug interactions with oral contraceptives. Drug Intell Clin Pharm. 1986;20(5):353-362. [PMID: 3519141]
188	Durr D, Stieger B, KullakUblick GA, Rentsch KM, Steinert HC, Meier PJ, Fattinger K "St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4." Clin Pharmacol Ther 68 (2000): 598-604. [PMID: 11180019]
189	Faculty of Sexual & Reproductive Healthcare "FSRH Clinical Guidance: Drug Interactions with Hormonal Contraception.".
190	Furlan AJ, Rothner AD "Anti-epileptic drugs and failure of oral contraceptives." Lancet 1 (1974): 1113. [PMID: 4135275]
191	Gorski JC, Hamman MA, Wang Z, Vasvada N, Huang S, Hall SD "The effect of St. John's wort on the efficacy of oral contraception." Clin Pharmacol Ther 71 (2002): P25. [PMID: 14663455]
192	Hall SD, Wang Z, Huang SM, et al. "The interaction between St John's wort and an oral contraceptive." Clin Pharmacol Ther 74 (2003): 525-35. [PMID: 14663455]
193	Halpenny O, Bye A, Cranny A, Feely J, Daly PA "Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate." Med Oncol Tumor Pharmacother 7 (1990): 241-7. [PMID: 2149401]
194	Janz D, Schmidt D "Letter: Anti-epileptic drugs and failure of oral contraceptives." Lancet 1 (1974): 1113. [PMID: 4135275]
195	Klosterskov Jensen P, Saano V, Haring P, Svenstrup B, Menge GP "Possible interaction between oxcarbazepine and an oral contraceptive." Epilepsia 33 (1992): 1149-52. [PMID: 1464278]
196	Laengner H, Detering K "Letter: Anti-epileptic drugs and failure of oral contraceptives." Lancet 2 (1974): 600. [PMID: 4140317]
197	LeBel M, Masson E, Guilbert E, Colborn D, Paquet F, Allard S, Vallee F, Narang PK "Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone." J Clin Pharmacol 38 (1998): 1042-50. [PMID: 9824786]
198	Mattson RH, Cramer JA, Darney PD, Naftolin F "Use of oral contraceptives by women with epilepsy." JAMA 256 (1986): 238-40. [PMID: 3723710]
199	McDaniel PA, Caldroney RD "Oral contraceptives and griseofulvin interaction." Drug Intell Clin Pharm 20 (1986): 384. [PMID: 3709350]
200	Michalets EL "Update: clinically significant cytochrome P-450 drug interactions." Pharmacotherapy 18 (1998): 84-112. [PMID: 9469685]
201	Mumford JP "Letter: Drugs affecting oral contraceptives." Br Med J 2 (1974): 333-4. [PMID: 4827122]
202	Nocke-finck L "Effects of rifampicin on menstral cycle and on estrogen excretion in patients taking oral contraceptives." JAMA 226 (1973): 378. [PMID: 4580141]
203	Notelovitz M, Tjapkes J, Ware M "Interaction between estrogen and dilantin in a menopausal woman." N Engl J Med 304 (1981): 788-9. [PMID: 6258075]
204	Pfrunder A, Schiesser M, Gerber S, Haschke M, Bitzer J, Drewe J "Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial." Br J Clin Pharmacol 56 (2003): 683-90. [PMID: 14616430]
205	Product Information. Premarin (conjugated estrogens). Wyeth-Ayerst Laboratories, Philadelphia, PA.
206	Murphy PA. St. John's wort and oral contraceptives: reasons for concern?.?J Midwifery Womens Health. 2002;47(6):447-450. doi:10.1016/s1526-9523(02)00321-5. [PMID: 12484666]
207	Skolnick JL, Stoler BS, Katz DB, Anderson WH "Rifampin, oral contraceptives, and pregnancy." JAMA 236 (1976): 1382. [PMID: 989097]
208	Strayhorn VA, Baciewicz AM, Self TH "Update on rifampin drug interactions, III." Arch Intern Med 157 (1997): 2453-8. [PMID: 9385296]
209	Szoka PR, Edgren RA "Drug interactions with oral contraceptives: compilation and analysis of an adverse experience report database." Fertil Steril 49 (1988): s31-8. [PMID: 3282933]
210	Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception. Br J Clin Pharmacol 55 (2003): 112-113. [PMID: 12534648]
211	van Dijke CP, Weber JC "Interaction between oral contraceptives and griseofulvin." Br Med J (Clin Res Ed) 288 (1984): 1125-6. [PMID: 2143563]
212	Venkatesan K "Pharmacokinetic drug interactions with rifampicin." Clin Pharmacokinet 22 (1992): 47-65. [PMID: 1559307]
213	Weaver K, Glasier A "Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill: a literature review." Contraception 59 (1999): 71-8. [PMID: 10361620]
214	Weber JC "Interaction between oral contraceptives and griseofulvin." Br Med J 288 (1984): 1125-6. [PMID: 6424759]
215	Weisberg E "Interactions between oral contraceptives and antifungals antibacterials - Is contraceptive failure the result?." Clin Pharmacokinet 36 (1999): 309-13. [PMID: 10384856]
216	Wilbur K, Ensom MHH "Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants." Clin Pharmacokinet 38 (2000): 355-65. [PMID: 10803456]
217	Zachariassen RD "Loss of oral contraceptive efficacy by concurrent antibiotic administration." Women Health 22 (1994): 17-26. [PMID: 7900401]
218	Lundgren S, Lonning PE, Aakvaag A, Kvinnsland S, Lnning PE "Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer." Cancer Chemother Pharmacol 27 (1990): 101-5. [PMID: 2249324]
219	Product Information. Aliqopa (copanlisib). Bayer Pharmaceutical Inc, West Haven, CT.
220	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
221	Product Information. Enablex (darifenacin). Novartis Pharmaceuticals, East Hanover, NJ.
222	Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
223	Product Information. Methergine (methylergonovine). Novartis Pharmaceuticals, East Hanover, NJ.
224	Aronson JK, Grahame-Smith DG "Clinical pharmacology: adverse drug interactions." Br Med J 282 (1981): 288-91. [PMID: 6779990]
225	Baker SD "Drug interactions with the taxanes." Pharmacotherapy 17(5 Pt 2) (1997): s126-32. [PMID: 9322879]
226	Komoroski BJ, Parise RA, Egorin MJ, Strom SC, Venkataramanan R "Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures." Clin Cancer Res 11(19 Pt 1) (2005): 6972-9. [PMID: 16203790]
227	McInnes GT, Brodie MJ "Drug interactions that matter: a critical reappraisal." Drugs 36 (1988): 83-110. [PMID: 3063497]
228	Product Information. Taxotere (docetaxel). Rhone-Poulenc Rorer, Collegeville, PA.
229	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
230	Product Information. Pifeltro (doravirine). Merck & Company Inc, Whitehouse Station, NJ.
231	Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
232	Product Information. Orilissa (elagolix). AbbVie US LLC, North Chicago, IL.
233	Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
234	Product Information. Cerdelga (eliglustat). Genzyme Corporation, Cambridge, MA.
235	Product Information. Vitekta (elvitegravir). Gilead Sciences, Foster City, CA.
236	Product Information. Balversa (erdafitinib). Janssen Products, LP, Horsham, PA.
237	Li J, Zhao M, He P, Hidalgo M, Baker SD "Differential metabolism of gefitinib and erlotinib by human cytochrome p450 enzymes." Clin Cancer Res 13 (2007): 3731-7. [PMID: 17575239]
238	Product Information. Tarceva (erlotinib). Genentech, South San Francisco, CA.
239	Product Information. Lunesta (eszopiclone). Sepracor Inc, Marlborough, MA.
240	Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
241	Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
242	Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
243	Product Information. Aromasin (exemestane) Pharmacia & Upjohn, Kalamazoo, MI.
244	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
245	Product Information. Toviaz (fesoterodine). Pfizer U.S. Pharmaceuticals Group, New York, NY.
246	Product Information. Addyi (flibanserin). Sprout Pharmaceuticals, Raleigh, NC.
247	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
248	Product Information. Iressa (gefitinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
249	Product Information. Mavyret (glecaprevir-pibrentasvir). Abbott Pharmaceutical, Abbott Park, IL.
250	Kiechel JR, Lavene D, Guerret M, Comoy E, Godin M, Fillastre JP "Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure." Eur J Clin Pharmacol 25 (1983): 463-6. [PMID: 6360692]
251	Product Information. Intuniv (guanfacine). Shire US Inc, Florence, KY.
252	Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
253	Crews KR, Stewart CF, Jones-Wallace D, et al "Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy." Clin Cancer Res 8 (2002): 2202-9. [PMID: 12114421]
254	Di YM, Li CG, Xue CC, Zhou SF "Clinical drugs that interact with St. John's wort and implication in drug development." Curr Pharm Des 14 (2008): 1723-42. [PMID: 18673195]
255	Friedman HS, Petros WP, Friedman AH, et al "Irinotecan therapy in adults with recurrent or progressive malignant glioma." J Clin Oncol 17 (1999): 1516-25. [PMID: 10334539]
256	Innocenti F, Undevia SD, Ramirez J, et al. "A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital." Clin Pharmacol Ther 76 (2004): 490-502. [PMID: 15536463]
257	Kuhn JG "Influence of anticonvulsants on the metabolism and elimination of irinotecan. A North American Brain Tumor Consortium preliminary report." Oncology (Williston Park 16(8 Suppl 7) (2002): 33-40. [PMID: 12199631]
258	Hu ZP, Yang XX, Chen X, et al. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.?Curr Drug Metab. 2007;8(2):157-171. [PMID: 17305494]
259	Mathijssen RH, Verweij J, De Bruijn P, Loos WJ, Sparreboom A "Effects of St. John's Wort on Irinotecan Metabolism." J Natl Cancer Inst 94 (2002): 1247-9. [PMID: 12189228]
260	Minami H, Lad TE, Nicholas MK, Vokes EE, Ratain MJ "Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studies." Clin Cancer Res 5 (1999): 1325-30. [PMID: 10389915]
261	Murry DJ, Cherrick I, Salama V, et al. "Influence of phenytoin on the disposition of irinotecan: a case report." J Pediatr Hematol Oncol 24 (2002): 130-3. [PMID: 11990699]
262	Product Information. Camptosar (irinotecan). Pharmacia and Upjohn, Kalamazoo, MI.
263	Product Information. Onivyde (irinotecan liposomal). Merrimack Pharmaceuticals, Cambridge, MA.
264	Hofland KF, Hansen S, Sorensen M, et al. Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.?Acta Oncol. 2014;53(7):939-944. [PMID: 24456504]
265	Santos A, Zanetta S, Cresteil T, et al "Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans." Clin Cancer Res 6 (2000): 2012-20. [PMID: 10815927]
266	Yonemori K, Takeda Y, Toyota E, Kobayashi N, Kudo K "Potential interactions between irinotecan and rifampin in a patient with small-cell lung cancer." Int J Clin Oncol 9 (2004): 206-9. [PMID: 15221608]
267	Zamboni WC, Gajjar AJ, Heideman RL, et al "Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma." Clin Cancer Res 4 (1998): 783-9. [PMID: 9533548]
268	Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
269	Product Information. Orkambi (ivacaftor-lumacaftor). Vertex Pharmaceuticals, Cambridge, MA.
270	Product Information. Symdeko 4-Week (ivacaftor-tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
271	Product Information. Trikafta (elexacaftor/ivacaftor/tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
272	Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
273	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
274	Product Information. Pemazyre (pemigatinib). Incyte Corporation, Wilmington, DE.
275	Product Information. Qinlock (ripretinib). Deciphera Pharmaceuticals, Waltham, MA.
276	Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
277	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
278	Product Information. Ixempra (ixabepilone). Bristol-Myers Squibb, Princeton, NJ.
279	Product Information. Ninlaro (ixazomib). Takeda Pharmaceuticals America, Lincolnshire, IL.
280	Product Information. Dayvigo (lemborexant). Eisai Inc, Woodcliff Lake, NJ.
281	Product Information. Tradjenta (linagliptin). Boehringer Ingelheim, Ridgefield, CT.
282	Eggleston W, Clark KH, Marraffa JM "Loperamide abuse associated with cardiac dysrhythmia and death." Ann Emerg Med 69 (2017): 83-6. [PMID: 27140747]
283	US Food and Drug Administration "FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse.".
284	Product Information. Latuda (lurasidone). Sunovion Pharmaceuticals Inc, Marlborough, MA.
285	Product Information. Zepzelca (lurbinectedin). Jazz Pharmaceuticals, Palo Alto, CA.
286	Bruderer S, Aanismaa P, Homery MC, et al. "Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist." AAPS J 14 (2012): 68-78. [PMID: 22189899]
287	Product Information. Opsumit (macitentan). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
288	Product Information. Selzentry (maraviroc). Pfizer U.S. Pharmaceuticals Group, New York, NY.
289	Product Information. Singulair (montelukast). Merck & Co, Inc, West Point, PA.
290	Product Information. Movantik (naloxegol). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
291	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
292	Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
293	Jamis-Dow CA, Klecker RW, Katki AG, Collins JM "Metabolism of Taxol by human liver microsomes and effect of inhibitors (Meeting abstract)." Proc Annu Meet Am Assoc Cancer Res 34 (1993): a21981993.
294	Product Information. Abraxane (paclitaxel protein-bound). American Pharmaceutical Partners, Schaumberg, IL.
295	Product Information. Taxol (paclitaxel). Bristol-Myers Squibb, Princeton, NJ.
296	Spencer CM, Faulds D "Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer." Drugs 48 (1994): 794-847. [PMID: 7530632]
297	Product Information. Ibrance (palbociclib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
298	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
299	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
300	Product Information. Iclusig (ponatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
301	Bittencourt PR, Gracia CM, Martins R, et al "Phenytoin and carbamazepine decrease oral bioavailability of praziquantel." Neurology 42 (1992): 492-6. [PMID: 1549207]
302	Product Information. Biltricide (praziquantel). Bayer, West Haven, CT.
303	Ridtitid W, Wongnawa M, Mahatthanatrakul W, Punyo J, Sunbhanich M "Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers." Clin Pharmacol Ther 72 (2002): 505-13. [PMID: 12426514]
304	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
305	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
306	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
307	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
308	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
309	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
310	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
311	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
312	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
313	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
314	Product Information. Rozerem (ramelteon). Takeda Pharmaceuticals America, Lincolnshire, IL.
315	Bidstrup TB, Bjornsdottir I, Sidelmann UG, Thomsen MS, Hansen KT "CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide." Br J Clin Pharmacol 56 (2003): 305-14. [PMID: 12919179]
316	Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT "Rifampin decreases the plasma concentrations and effects of repaglinide." Clin Pharmacol Ther 68 (2000): 495-500. [PMID: 11103752]
317	Product Information. Prandin (repaglinide). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
318	Product Information. Adempas (riociguat). Bayer Pharmaceutical Inc, West Haven, CT.
319	Product Information. Xarelto (rivaroxaban). Bayer Inc, Toronto, IA.
320	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
321	Product Information. Jakafi (ruxolitinib). Incyte Corporation, Wilmington, DE.
322	Product Information. Onglyza (saxagliptin). Bristol-Myers Squibb, Princeton, NJ.
323	Product Information. Koselugo (selumetinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
324	Hyland R, Roe GH, Jones BC, Smith DA "Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil." Br J Clin Pharmaacol 51 (2001): 239-48. [PMID: 11298070]
325	Product Information. Revatio (sildenafil). Pfizer U.S. Pharmaceuticals Group, New York, NY.
326	Product Information. Viagra (sildenafil). Pfizer US Pharmaceuticals, New York, NY.
327	Warrington JS, Shader RI, vonMoltke LL, Greenblatt DJ "In vitro biotransformation of sildenafil (Viagra): Identification of human cytochromes and potential drug interactions." Drug Metab Disposition 28 (2000): 392-7. [PMID: 10725306]
328	Product Information. Rapaflo (silodosin). Watson Pharmaceuticals, Corona, CA.
329	Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
330	Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
331	Product Information. Odomzo (sonidegib). Novartis Pharmaceuticals, East Hanover, NJ.
332	Product Information. Belsomra (suvorexant). Merck & Company Inc, Whitehouse Station, NJ.
333	Product Information. Adcirca (tadalafil). United Therapeutics Corporation, Silver Spring, MD.
334	Product Information. Cialis (tadalafil). Lilly, Eli and Company, Indianapolis, IN.
335	Product Information. Hetlioz (tasimelteon). Vanda Pharmaceuticals Inc, Rockville, MD.
336	Product Information. Torisel (temsirolimus). Wyeth-Ayerst Laboratories, Philadelphia, PA.
337	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
338	Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
339	Teng R, Mitchell P, Butler K "Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects." Eur J Clin Pharmacol 69 (2013): 877-83. [PMID: 23093043]
340	Weeks P, Sieg A, Vahdat K, Raissi F, Nathan S "Improved ticagrelor antiplatelet effect on discontinuation of phenytoin." Ann Pharmacother 48 (2014): 644-7. [PMID: 24477376]
341	Acosta EP, Henry K, Baken L, Page LM, Fletcher CV "Indinavir concentrations and antiviral effect." Pharmacotherapy 19 (1999): 708-12. [PMID: 10391416]
342	Barry M, Gibbons S, Back D, Mulcahy F "Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations." Clin Pharmacokinet 32 (1997): 194-209. [PMID: 9084959]
343	Brooks J, Daily J, Schwamm L "Protease inhibitors and anticonvulsants." AIDS Clin Care 9 (1997): 87,90. [PMID: 11364776]
344	Hugen PWH, Burger DM, Brinkman K, terHofstede HJM, Schuurman R, Koopmans PP, Hekster YA "Carbamazepine-indinavir interaction causes antiretroviral therapy failure." Ann Pharmacother 34 (2000): 465-70. [PMID: 10772431]
345	Liedtke MD, Lockhart SM, Rathbun RC "Anticonvulsant and antiretroviral interactions." Ann Pharmacother 38 (2004): 482-9. [PMID: 14970370]
346	Product Information. Agenerase (amprenavir). Glaxo Wellcome, Research Triangle Pk, NC.
347	Product Information. Aptivus (tipranavir). Boehringer-Ingelheim, Ridgefield, CT.
348	Product Information. Crixivan (indinavir). Merck & Co, Inc, West Point, PA.
349	Product Information. Fortovase (saquinavir) Roche Laboratories, Nutley, NJ.
350	Product Information. Lexiva (fosamprenavir). GlaxoSmithKline, Research Triangle Park, NC.
351	Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
352	Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
353	Product Information. Viracept (nelfinavir). Agouron Pharma Inc, La Jolla, CA.
354	Sommadossi JP "HIV protease inhibitors: pharmacologic and metabolic distinctions." AIDS 13 (1999): s29-40. [PMID: 10546783]
355	Durant J, Clevenbergh P, Garraffo R, Halfon P, Icard S, DelGiudice P, Montagne N, Schapiro JM, Dellamonica P "Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study." Aids 14 (2000): 1333-9. [PMID: 10930147]
356	Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
357	Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
358	Machiels JP, Staddon A, Herremans C, et al. "Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies." Cancer Chemother Pharmacol 74 (2014): 729-37. [PMID: 25100135]
359	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
360	Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
361	Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
362	Skillman TG, Feldman JM "The pharmacology of sulfonylureas." Am J Med 70 (1981): 361-72. [PMID: 6781341]
363	Product Information. Viibryd (vilazodone). Trovis Pharmaceuticals LLC, New Haven, CT.
364	Product Information. Brintellix (vortioxetine). Takeda Pharmaceuticals America, Lincolnshire, IL.
365	Product Information. Ambien (zolpidem). sanofi-aventis, Bridgewater, NJ.
366	Villikka K, Kivisto KT, Luurila H, Neuvonen PJ "Rifampin reduces plasma concentrations and effects of zolpidem." Clin Pharmacol Ther 62 (1997): 629-34. [PMID: 9433391]
367	Vlase L, Popa A, Neag M, Muntean D, Baldea I, Leucuta SE "Pharmacokinetic Interaction Between Zolpidem and Carbamazepine in Healthy Volunteers." J Clin Pharmacol (2010):. [PMID: 21098143]
368	Nakasa H, Nakamura H, Ono S, Tsutsui M, Kiuchi M, Ohmori S, Kitada M "Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data." Eur J Clin Pharmacol 54 (1998): 177-83. [PMID: 9626925]
369	Product Information. Zonegran (zonisamide) Elan Pharmaceuticals, S. San Francisco, CA.
370	Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
371	Hellmann A, Rule S, Walewski J, et al. "Effect of cytochrome P450 3A4 inducers on the pharmacokinetic, pharmacodynamic and safety profiles of bortezomib in patients with multiple myeloma or Non-Hodgkin's lymphoma." Clin Pharmacokinet 50 (2011): 781-91. [PMID: 22087865]
372	Pekol T, Daniels JS, Labutti J, et al "Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites." Drug Metab Dispos 33 (2005): 771-7. [PMID: 15764713]
373	Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
374	Uttamsingh V, Lu C, Miwa GT, Gan LS "Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4 to the hepatic metabolism of teh protosome inhibitor bortezomib." Drug Metab Dispos 33 (2005): 1723-8. [PMID: 16103134]
375	Product Information. Evoxac (cevimeline) Daiichi Pharmaceuticals, Fort lee, NJ.
376	Product Information. Aczone (dapsone topical). QLT USA, Inc, Fort Collins, CO.
377	Product Information. Tivicay (dolutegravir). ViiV Healthcare, Research Triangle Park, NC.
378	Product Information. Chirocaine (levobupivacaine) Organon, West Orange, NJ.
379	Heinonen J, Takki S, Jarho L "Plasma lidocaine levels in patients treated with potential inducers of microsomal enzymes." Acta Anaesthesiol Scand 14 (1970): 89-95. [PMID: 5428253]
380	Perucca E, Richens A "Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients." Br J Clin Pharmacol 8 (1979): 21-31. [PMID: 552293]
381	Perucca E, Ruprah M, Richens A, Park BK, Betteridge DJ, Hedges AM "Effect of low-dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects." Br J Clin Pharmacol 12 (1981): 592-6. [PMID: 6117310]
382	Reichel C, Skodra T, Nacke A, Spengler U, Sauerbruch T "The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans." Br J Clin Pharmacol 46 (1998): 535-9. [PMID: 9862241]
383	Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F "QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone." Pacing Clin Electrophysiol 28 (2005): 472-3. [PMID: 15869686]
384	Product Information. Flagyl (metronidazole). Searle, Skokie, IL.
385	Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma, Birmingham, AL.
386	Product Information. Myrbetriq (mirabegron). Astellas Pharma US, Inc, Deerfield, IL.
387	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence